Activity of enzalutamide in men with metastatic castration-resistant prostate cancer is affected by prior treatment with abiraterone and/or docetaxel

H. H. Cheng, R. Gulati, A. Azad, R. Nadal, P. Twardowski, U. N. Vaishampayan, N. Agarwal, E. I. Heath, S. K. Pal, H. T. Rehman, A. Leiter, J. A. Batten, R. B. Montgomery, M. D. Galsky, E. S. Antonarakis, K. N. Chi, E. Y. Yu

Research output: Contribution to journalArticlepeer-review

67 Scopus citations

Fingerprint

Dive into the research topics of 'Activity of enzalutamide in men with metastatic castration-resistant prostate cancer is affected by prior treatment with abiraterone and/or docetaxel'. Together they form a unique fingerprint.

Medicine & Life Sciences